Stay updated with breaking news from Nasdaq Ensc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 56,500 shares, a drop of 34.4% from the February 29th total of 86,100 shares. Based on an average daily volume of 1,440,000 shares, the short-interest ratio […]
Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 61,100 shares, a drop of 91.0% from the January 31st total of 678,500 shares. Based on an average daily volume of 1,500,000 shares, […]
Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 167,000 shares, an increase of 25.3% from the November 30th total of 133,300 shares. Based on an average trading volume of 198,900 shares, […]
Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 23,300 shares, a growth of 9.9% from the September 30th total of 21,200 shares. Approximately 0.9% of the shares of the stock are […]
Ensysce Biosciences (NASDAQ:ENSC – Free Report) had its target price lowered by HC Wainwright from $9.00 to $7.00 in a research report sent to investors on Monday morning, MarketBeat.com reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Ensysce Biosciences’ Q3 2023 earnings at ($0.93) EPS, Q4 […]